1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        SAM Intravenous Immunoglobulin Market – By Type

1.3.2        SAM Intravenous Immunoglobulin Market – By Application

1.3.3        SAM Intravenous Immunoglobulin Market – By Distribution Channel

1.3.4        SAM Intravenous Immunoglobulin Market – By End User

1.3.5        SAM Intravenous Immunoglobulin Market – By Country

2.           SAM Intravenous Immunoglobulin Market– Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           SAM Intravenous Immunoglobulin Market – Market Landscape

4.1         Overview

4.2         SAM PEST Analysis

4.3         Expert Opinion

5.           SAM Intravenous Immunoglobulin Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Prevalence of Immunodeficiency Diseases

5.1.2        Increasing Geriatric Population

5.2         Market Restraints

5.2.1        Adverse Effects of Immunoglobulin Therapy

5.3         Future Trends

5.3.1        Strong Pipeline Candidates for IVIG

5.4         Impact Analysis

6.           Intravenous Immunoglobulin Market– SAM Analysis

6.1         SAM Intravenous Immunoglobulin Market Revenue Forecast and Analysis

7.           SAM Intravenous Immunoglobulin Market Revenue and Forecast to 2028– by Type

7.1         Overview

7.2         SAM Intravenous Immunoglobulin Market, By Type 2022 & 2028 (%)

7.3         IgG

7.3.1        Overview

7.3.2        IgG Revenue and Forecast to 2028 (US$ Million)

7.4         IgM

7.4.1        Overview

7.4.2        IgM - Revenue and Forecast to 2028 (US$ Million)

7.5         IgA

7.5.1        Overview

7.5.2        IgA - Revenue and Forecast to 2028 (US$ Million)

7.6         IgE

7.6.1        Overview

7.6.2        IgE - Revenue and Forecast to 2028 (US$ Million)

7.7         IgD

7.7.1        Overview

7.7.2        IgD - Revenue and Forecast to 2028 (US$ Million)

8.           SAM Intravenous Immunoglobulin Market Revenue and Forecast to 2028 – by Application

8.1         Overview

8.2         SAM Intravenous Immunoglobulin Market, By Application 2022 & 2028 (%)

8.3         Hypogammaglobulinemia

8.3.1        Overview

8.3.2        Hypogammaglobulinemia - Market Revenue and Forecast to 2028 (US$ Million)

8.4         Chronic Inflammatory Demyelinating Polyneuropathy

8.4.1        Overview

8.4.2        Chronic Inflammatory Demyelinating Polyneuropathy - Market Revenue and Forecast to 2028 (US$ Million)

8.5         Immunodeficiency Diseases

8.5.1        Overview

8.5.2        Immunodeficiency Diseases - Market Revenue and Forecast to 2028 (US$ Million)

8.6         Myasthenia Gravis

8.6.1        Overview

8.6.2        Myasthenia Gravis - Market Revenue and Forecast to 2028 (US$ Million)

8.7         Multifocal Motor Neuropathy

8.7.1        Overview

8.7.2        Multifocal Motor Neuropathy - Market Revenue and Forecast to 2028 (US$ Million)

8.8         Idiopathic Thrombocytopenic Purpura

8.8.1        Overview

8.8.2        Idiopathic Thrombocytopenic Purpura - Market Revenue and Forecast to 2028 (US$ Million)

8.9         Inflammatory Myopathies

8.9.1        Overview

8.9.2        Inflammatory Myopathies - Market Revenue and Forecast to 2028 (US$ Million)

8.10      Specific Antibody Deficiency

8.10.1     Overview

8.10.2     Specific Antibody Deficiency - Market Revenue and Forecast to 2028 (US$ Million)

8.11      Guillain-Barre Syndrome

8.11.1     Overview

8.11.2     Guillain-Barre Syndrome - Market Revenue and Forecast to 2028 (US$ Million)

8.12      Others

8.12.1     Overview

8.12.2     Others - Market Revenue and Forecast to 2028 (US$ Million)

9.           SAM Intravenous Immunoglobulin Market Revenue and Forecast to 2028 – by Distribution Channel

9.1         Overview

9.2         SAM Intravenous Immunoglobulin Market, By Distribution Channel 2022 & 2028 (%)

9.3         Hospital Pharmacy

9.3.1        Overview

9.3.2        Hospital Pharmacy - Market Revenue and Forecast to 2028 (US$ Million)

9.4         Retail Pharmacy

9.4.1        Overview

9.4.2        Retail Pharmacy - Market Revenue and Forecast to 2028 (US$ Million)

9.5         Others

9.5.1        Overview

9.5.2        Others - Market Revenue and Forecast to 2028 (US$ Million)

10.        SAM Intravenous Immunoglobulin Market Revenue and Forecast to 2028 – by End User

10.1      Overview

10.2      SAM Intravenous Immunoglobulin Market, By End User 2022 & 2028 (%)

10.3      Hospitals

10.3.1     Overview

10.3.2     Hospitals - Market Revenue And Forecasts To 2028 (US$ Million)

10.4      Specialty Clinics

10.4.1     Overview

10.4.2     Specialty Clinics - Market Revenue And Forecasts To 2028 (US$ Million)

10.5      Others

10.5.1     Overview

10.5.2     Others - Market Revenue And Forecasts To 2028 (US$ Million)

11.        SAM Intravenous Immunoglobulin Market Revenue and Forecasts to 2028 – Country Analysis

11.1      Overview

11.1.1     SAM: Intravenous Immunoglobulin Market, by Country, 2022 & 2028 (%)

11.1.1.1       Brazil: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.1.1       Overview

11.1.1.1.2       Brazil: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.1.3       Brazil: Intravenous Immunoglobulin Market, by Type, 2019–2028 (USD Million)

11.1.1.1.4       Brazil: Intravenous Immunoglobulin Market, by Application, 2019–2028 (USD Million)

11.1.1.1.5       Brazil: Intravenous Immunoglobulin Market, by Distribution Channel, 2019–2028 (USD Million)

11.1.1.1.6       Brazil: Intravenous Immunoglobulin Market, by End User, 2019–2028 (USD Million)

11.1.1.2       Argentina: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.2.1       Overview

11.1.1.2.2       Argentina: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.2.3       Argentina: Intravenous Immunoglobulin Market, by Type, 2019–2028 (USD Million)

11.1.1.2.4       Argentina: Intravenous Immunoglobulin Market, by Application, 2019–2028 (USD Million)

11.1.1.2.5       Argentina: Intravenous Immunoglobulin Market, by Distribution Channel, 2019–2028 (USD Million)

11.1.1.2.6       Argentina: Intravenous Immunoglobulin Market, by End User, 2019–2028 (USD Million)

11.1.1.3       Rest of SAM: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.3.1       Overview

11.1.1.3.2       Rest of SAM: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.3.3       Rest of SAM: Intravenous Immunoglobulin Market, by Type, 2019–2028 (USD Million)

11.1.1.3.4       Rest of SAM: Intravenous Immunoglobulin Market, by Application, 2019–2028 (USD Million)

11.1.1.3.5       Rest of SAM: Intravenous Immunoglobulin Market, by Distribution Channel, 2019–2028 (USD Million)

11.1.1.3.6       Rest of SAM: Intravenous Immunoglobulin Market, by End User, 2019–2028 (USD Million)

12.        SAM Intravenous Immunoglobulin Market–Industry Landscape

12.1      Overview

12.2      Inorganic Growth Strategies

12.2.1     Overview

12.3      Organic Growth Strategies

12.3.1     Overview

13.        Company Profiles

13.1      Takeda Pharmaceutical Company Limited

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Grifols, S.A.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Pfizer Inc.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      ADMA Biologics, Inc.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Bio Products Laboratory Ltd.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Shanghai RAAS

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Octapharma AG

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Kedrion S.p.A

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      CSL Behring (CSL Limited)

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   Prothya Biosolutions B.V.

13.10.1  Key Facts

13.10.2  Business Description

13.10.3  Products and Services

13.10.4  Financial Overview

13.10.5  SWOT Analysis

13.10.6  Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms in Intravenous Immunoglobulin Market

LIST OF TABLES

Table 1.             SAM Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (US$ Million)

Table 2.             Brazil: Intravenous Immunoglobulin Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 3.             Brazil: Intravenous Immunoglobulin Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 4.             Brazil: Intravenous Immunoglobulin Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 5.             Brazil: Intravenous Immunoglobulin Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 6.             Argentina: Intravenous Immunoglobulin Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 7.             Argentina: Intravenous Immunoglobulin Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 8.             Argentina: Intravenous Immunoglobulin Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 9.             Argentina: Intravenous Immunoglobulin Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 10.          Rest of SAM: Intravenous Immunoglobulin Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 11.          Rest of SAM: Intravenous Immunoglobulin Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 12.          Rest of SAM: Intravenous Immunoglobulin Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 13.          Rest of SAM: Intravenous Immunoglobulin Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 14.          Recent Inorganic Growth Strategies in the Intravenous Immunoglobulin Market

Table 15.          Recent Organic Growth Strategies in the Intravenous Immunoglobulin Market

Table 16.          Glossary of Terms in Intravenous Immunoglobulin Market

LIST OF FIGURES

Figure 1.           SAM Intravenous Immunoglobulin Market Segmentation

Figure 2.           SAM Intravenous Immunoglobulin Market Segmentation, By Country

Figure 3.           SAM Intravenous Immunoglobulin Market Overview

Figure 4.           SAM Intravenous Immunoglobulin Market, by Type

Figure 5.           SAM Intravenous Immunoglobulin Market, by Country

Figure 6.           SAM: PEST Analysis

Figure 7.           Impact Analysis

Figure 8.           SAM Intravenous Immunoglobulin Market– Revenue Forecast and Analysis – 2020 - 2028

Figure 9.           SAM Intravenous Immunoglobulin Market, by Type 2022 & 2028 (%)

Figure 10.        SAM IgG Revenue and Forecasts to 2028 (US$ Million)

Figure 11.        SAM IgM - Revenue and Forecasts to 2028 (US$ Million)

Figure 12.        SAM IgA - Revenue and Forecasts to 2028 (US$ Million)

Figure 13.        SAM IgE - Revenue and Forecasts to 2028 (US$ Million)

Figure 14.        SAM IgD - Revenue and Forecasts to 2028 (US$ Million)

Figure 15.        SAM Intravenous Immunoglobulin Market, by Application 2022 & 2028 (%)

Figure 16.        SAM Hypogammaglobulinemia - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17.        SAM Chronic Inflammatory Demyelinating Polyneuropathy - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18.        SAM Immunodeficiency Diseases - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19.        SAM Myasthenia Gravis - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 20.        SAM Multifocal Motor Neuropathy - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21.        SAM Idiopathic Thrombocytopenic Purpura - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22.        SAM Inflammatory Myopathies - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 23.        SAM Specific Antibody Deficiency - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 24.        SAM Guillain-Barre Syndrome - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25.        SAM Others - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 26.        SAM Intravenous Immunoglobulin Market, by Distribution Channel 2022 & 2028 (%)

Figure 27.        SAM Hospital Pharmacy - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 28.        SAM Retail Pharmacy - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 29.        SAM Others - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 30.        SAM Intravenous Immunoglobulin Market, by End User 2022 & 2028 (%)

Figure 31.        SAM Hospitals - Market Revenue And Forecasts To 2028 (US$ Million)

Figure 32.        SAM Specialty Clinics - Market Revenue And Forecasts To 2028 (US$ Million)

Figure 33.        SAM Others- Market Revenue And Forecasts To 2028 (US$ Million)

Figure 34.        SAM: Intravenous Immunoglobulin Market, by Key Country – Revenue (2022) (USD Million)

Figure 35.        SAM: Intravenous Immunoglobulin Market, by Country, 2022 & 2028 (%)

Figure 36.        Brazil: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (USD Million)

Figure 37.        Argentina: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (USD Million)

Figure 38.        Rest of SAM: Intravenous Immunoglobulin Market – Revenue and Forecast to 2028 (USD Million)